Next, we collected 82 pairs of matched RCC tumors and corresponding normal kidney tissues from human patients and measured HSPA12A protein expression, which was downregulated by 28.3% in cytosolic and 37.3% in pellet fractions of RCC tumors compared with their normal counterparts (Figure 1B). The gene discussed is HSPA12A; the disease is renal cell adenocarcinoma.